Amundi
IDXX icon

Amundi’s Idexx Laboratories IDXX Stock Holding History

Amundi’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343M Sell
610,779
-7,964
-1% -$5.11M 0.09% 200
2025
Q4 		$419M Buy
618,743
+26,144
+4% +$17.8M 0.11% 181
2025
Q3 		$372M Sell
592,599
-83,073
-12% -$50.4M 0.12% 147
2025
Q2 		$367M Sell
675,672
-47,439
-7% -$22.7M 0.13% 159
2025
Q1 		$297M Sell
723,111
-35,558
-5% -$15.4M 0.11% 192
2024
Q4 		$328M Buy
758,669
+56,837
+8% +$24.9M 0.11% 173
2024
Q3 		$334M Buy
701,832
+127,333
+22% +$61.9M 0.12% 169
2024
Q2 		$274M Sell
574,499
-175,505
-23% -$88.1M 0.11% 192
2024
Q1 		$358M Sell
750,004
-3,500
-0.5% -$1.91M 0.15% 147
2023
Q4 		$417M Buy
753,504
+141,439
+23% +$66.4M 0.19% 129
2023
Q3 		$261M Buy
612,065
+29,589
+5% +$14.8M 0.13% 187
2023
Q2 		$286M Buy
582,476
+84,540
+17% +$40.5M 0.14% 165
2023
Q1 		$237M Buy
497,936
+41,429
+9% +$19.8M 0.13% 179
2022
Q4 		$211M Buy
456,507
+52,514
+13% +$20.4M 0.12% 197
2022
Q3 		$141M Buy
403,993
+18,852
+5% +$6.93M 0.08% 266
2022
Q2 		$141M Buy
385,141
+69,177
+22% +$28.2M 0.11% 202
2022
Q1 		$174M Sell
315,964
-145,484
-32% -$76.5M 0.12% 198
2021
Q4 		$247M Buy
461,448
+64,757
+16% +$40.7M 0.16% 161
2021
Q3 		$247M Buy
396,691
+42,930
+12% +$28.8M 0.17% 144
2021
Q2 		$223M Buy
+353,761
New +$195M 0.16% 159

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi's IDXX Position: Q1 2026 in Review

Amundi reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q1 2026, selling an estimated $5.11M and leaving 610,779 shares worth $343M. The position accounts for 0.09% of the portfolio, ranked #200.

Amundi first reported a position in IDXX in Q2 2021 and has held it in 20 quarters since. The position peaked at $419M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Amundi held 610,779 shares of Idexx Laboratories worth $343M as of Q1 2026.
  • Amundi sold 7,964 Idexx Laboratories shares in Q1 2026, an estimated $5.11M.
  • Idexx Laboratories made up 0.09% of Amundi's portfolio in Q1 2026, its #200 holding.
  • Amundi first reported a position in Idexx Laboratories in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Idexx Laboratories position peaked at $419M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.